Pulmonary Embolism Market Report 2026
Download Free Sample Buy Now
Pulmonary Embolism Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Pulmonary Embolism Market Report 2026

Global Outlook – By Treatment (Medications, Mechanical Devices, Other Treatments), By Diagnosis (Chest X-Ray, Electrocardiogram (ECG), Magnetic Resonance Imaging (MRI), Computed Tomography Scan, Pulmonary Angiography, Venography, Venous Ultrasound, D-Dimer Test, Other Diagnosis), By Symptoms (Shortness Of Breath, Chest Pain, Cough, Irregular Heartbeat, Dizziness, Fever, Cyanosis, Other Symptoms), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels), By End-User (Hospitals, Specialty Clinics, Homecare, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Pulmonary Embolism Market Overview

• Pulmonary Embolism market size has reached to $2.26 billion in 2025

• Expected to grow to $4.14 billion in 2030 at a compound annual growth rate (CAGR) of 13.1%

• Growth Driver: Increasing Prevalence Of Cancer To Drive The Growth Of Pulmonary Embolism Market

• Market Trend: Leading Companies In The Pulmonary Embolism Market Innovate With Advanced Catheter Solutions

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Pulmonary Embolism Market?

A pulmonary embolism is a blockage in the pulmonary artery, which transports blood from the heart to the lungs. It causes the clot of blood that has gone to the lungs from another area of the body, most commonly the legs, which causes blockage. The symptoms of pulmonary embolism might range from abrupt shortness of breath to chest pain, coughing up blood or bloody mucus and others, depending on the severity of the clot.

The main types of treatment for pulmonary embolism are medications, mechanical devices, surgery and others. Medications refer to substances used for medical treatment, management, prevention, or relief of various medical conditions and illnesses. It is diagnosed with various methods, such as a chest X-ray, electrocardiogram (ECG), magnetic resonance imaging (MRI), computed tomography scan, pulmonary angiography, venography, venous ultrasound, D-Dimer test and others. It has various symptoms such as shortness of breath, chest pain, cough, irregular heartbeat, dizziness, fever, cyanosis and others and its drugs are mainly distributed through hospital pharmacies, retail pharmacies, online pharmacies and others. The main end-users are hospitals, specialty clinics, homecare and others.

Pulmonary Embolism Market Global Report 2026 Market Report bar graph

What Is The Pulmonary Embolism Market Size and Share 2026?

The pulmonary embolism market size has grown rapidly in recent years. It will grow from $2.26 billion in 2025 to $2.53 billion in 2026 at a compound annual growth rate (CAGR) of 12.0%. The growth in the historic period can be attributed to increasing incidence of cardiovascular and thromboembolic disorders, expansion of hospital emergency care services, wider use of anticoagulant medications, growing awareness of pulmonary embolism symptoms, availability of advanced diagnostic imaging.

What Is The Pulmonary Embolism Market Growth Forecast?

The pulmonary embolism market size is expected to see rapid growth in the next few years. It will grow to $4.14 billion in 2030 at a compound annual growth rate (CAGR) of 13.1%. The growth in the forecast period can be attributed to increasing investments in advanced anticoagulant drugs, rising adoption of catheter-based intervention techniques, expansion of early diagnostic screening programs, growing focus on outpatient management strategies, increasing demand for personalized cardiovascular care. Major trends in the forecast period include increasing adoption of novel anticoagulant therapies, rising use of minimally invasive thrombectomy devices, growing focus on early and accurate diagnosis, expansion of integrated care pathways, enhanced emphasis on risk stratification and prevention.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Pulmonary Embolism Market Segmentation

1) By Treatment: Medications, Mechanical Devices, Other Treatments

2) By Diagnosis: Chest X-Ray, Electrocardiogram (ECG), Magnetic Resonance Imaging (MRI), Computed Tomography Scan, Pulmonary Angiography, Venography, Venous Ultrasound, D-Dimer Test, Other Diagnosis

3) By Symptoms: Shortness Of Breath, Chest Pain, Cough, Irregular Heartbeat, Dizziness, Fever, Cyanosis, Other Symptoms

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

5) By End-User: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:

1) By Medications: Anticoagulants, Thrombolytics

2) By Mechanical Devices: Inferior Vena Cava (IVC) Filters, Catheter-Assisted Thrombectomy

3) By Other Treatments: Surgical Embolectomy, Supportive Care

What Is The Driver Of The Pulmonary Embolism Market?

The increasing prevalence of cancer is expected to propel the growth of the pulmonary embolism market. Cancer refers to a group of diseases characterized by the uncontrolled and abnormal growth of cells in the body. Increasing cancer prevalence raises the risk of blood clots, such as pulmonary embolism, in cancer patients. This leads to greater demand for diagnostics and treatments, including specialized drugs. For instance, in January 2024, according to the American Cancer Society, a US-based nonprofit cancer advocacy organization, the number of cancer cases increased to 2,001,140 compared to 1,958,310 in 2023, reflecting a growth of 2.19%. Therefore, the increasing prevalence of cancer is driving the growth of the pulmonary embolism industry.

Key Players In The Global Pulmonary Embolism Market

Major companies operating in the pulmonary embolism market are Pfizer Inc., Johnson And Johnson Private Limited, F Hoffmann La Roche Ltd., Merck And Co Inc., Novartis AG, Bayer AG, Sanofi S.A., Bristol Myers Squibb Company, GSK plc, Abbott Laboratories, AstraZeneca plc, Medtronic plc, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Daiichi Sankyo Co. Ltd., Boehringer Ingelheim International GmbH, Mitsubishi Tanabe Pharma Corporation, Genentech Inc., Hikma Pharmaceuticals plc, Aspen Pharmacare Holdings Limited, Nippon Shinyaku Co. Ltd., Fresenius Kabi AG, Inari Medical Inc., AngioDynamics Inc., Otsuka Pharmaceutical Co. Ltd., CSL Behring GmbH, Grifols S.A., Octapharma AG, Kedrion S.p.A

Global Pulmonary Embolism Market Trends and Insights

Major companies operating in the pulmonary embolism market are focused on developing innovative products such as the Triever16 Curve catheter and the RevCore thrombectomy catheter to gain a competitive advantage. For instance, in June 2023, Inari Medical Inc., a US-based medical device company, launched the Triever16 Curve catheter and the RevCore thrombectomy catheter. This innovative Triever16 Curve catheter is designed for peripheral thrombectomy and pulmonary embolism procedures. It is highly trackable and has a pre-shaped curve for focused aspiration. The catheter also features a unique design that allows easy access to larger and more powerful 20F or 24F catheters and the RevCore thrombectomy catheter is designed to treat venous in-stent thrombosis. It is a mechanical thrombectomy device that uses a nitinol basket to capture and remove blood clots. Moreover, these catheters also improve the safety and effectiveness of pulmonary embolism procedures.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Pulmonary Embolism Market?

In February 2025, Stryker Corporation, a US-based provider of medical technologies, acquired Inari Medical Inc. for an undisclosed amount. With this acquisition, Stryker aims to expand its presence in the high-growth peripheral vascular market and diversify its cardiovascular product portfolio. Inari Medical Inc. is a US-based company that provides treatments for pulmonary embolism (PE) through its FlowTriever system.

Regional Outlook

North America was the largest region in the pulmonary embolism market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Pulmonary Embolism Market?

The pulmonary embolism market consists of revenues earned by entities by providing services such as medical management, thrombolytic therapy, monitoring and oxygen therapy services. The market value includes the value of related goods sold by the service provider or included within the service offering. The pulmonary embolism market also includes sales of diagnostic imaging equipment, oxygen delivery devices, interventional devices, medical alert systems and pulse oximeters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Pulmonary Embolism Market Report 2026?

The pulmonary embolism market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pulmonary embolism industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Pulmonary Embolism Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $2.53 billion
Revenue Forecast In 2035 $4.14 billion
Growth Rate CAGR of 12.0% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Treatment, Diagnosis, Symptoms, Distribution Channel, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Pfizer Inc., Johnson And Johnson Private Limited, F Hoffmann La Roche Ltd., Merck And Co Inc., Novartis AG, Bayer AG, Sanofi S.A., Bristol Myers Squibb Company, GSK plc, Abbott Laboratories, AstraZeneca plc, Medtronic plc, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Daiichi Sankyo Co. Ltd., Boehringer Ingelheim International GmbH, Mitsubishi Tanabe Pharma Corporation, Genentech Inc., Hikma Pharmaceuticals plc, Aspen Pharmacare Holdings Limited, Nippon Shinyaku Co. Ltd., Fresenius Kabi AG, Inari Medical Inc., AngioDynamics Inc., Otsuka Pharmaceutical Co. Ltd., CSL Behring GmbH, Grifols S.A., Octapharma AG, Kedrion S.p.A
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Pulmonary Embolism Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Pulmonary Embolism Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Pulmonary Embolism Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Pulmonary Embolism Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Adoption Of Novel Anticoagulant Therapies

4.2.2 Rising Use Of Minimally Invasive Thrombectomy Devices

4.2.3 Growing Focus On Early And Accurate Diagnosis

4.2.4 Expansion Of Integrated Care Pathways

4.2.5 Enhanced Emphasis On Risk Stratification And Prevention

5. Pulmonary Embolism Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Clinics

5.3 Emergency Care Centers

5.4 Homecare Providers

5.5 Diagnostic Centers

6. Pulmonary Embolism Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Pulmonary Embolism Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Pulmonary Embolism PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Pulmonary Embolism Market Size, Comparisons And Growth Rate Analysis

7.3. Global Pulmonary Embolism Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Pulmonary Embolism Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Pulmonary Embolism Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Pulmonary Embolism Market Segmentation

9.1. Global Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Medications, Mechanical Devices, Other Treatments

9.2. Global Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Chest X-Ray, Electrocardiogram (ECG), Magnetic Resonance Imaging (MRI), Computed Tomography Scan, Pulmonary Angiography, Venography, Venous Ultrasound, D-Dimer Test, Other Diagnosis

9.3. Global Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Shortness Of Breath, Chest Pain, Cough, Irregular Heartbeat, Dizziness, Fever, Cyanosis, Other Symptoms

9.4. Global Pulmonary Embolism Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

9.5. Global Pulmonary Embolism Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Specialty Clinics, Homecare, Other End-Users

9.6. Global Pulmonary Embolism Market, Sub-Segmentation Of Medications, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Anticoagulants, Thrombolytics

9.7. Global Pulmonary Embolism Market, Sub-Segmentation Of Mechanical Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Inferior Vena Cava (IVC) Filters, Catheter-Assisted Thrombectomy

9.8. Global Pulmonary Embolism Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Surgical Embolectomy, Supportive Care

10. Pulmonary Embolism Market Regional And Country Analysis

10.1. Global Pulmonary Embolism Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Pulmonary Embolism Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Pulmonary Embolism Market

11.1. Asia-Pacific Pulmonary Embolism Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Pulmonary Embolism Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Pulmonary Embolism Market

12.1. China Pulmonary Embolism Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Pulmonary Embolism Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Pulmonary Embolism Market

13.1. India Pulmonary Embolism Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Pulmonary Embolism Market

14.1. Japan Pulmonary Embolism Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Pulmonary Embolism Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Pulmonary Embolism Market

15.1. Australia Pulmonary Embolism Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Pulmonary Embolism Market

16.1. Indonesia Pulmonary Embolism Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Pulmonary Embolism Market

17.1. South Korea Pulmonary Embolism Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Pulmonary Embolism Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Pulmonary Embolism Market

18.1. Taiwan Pulmonary Embolism Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Pulmonary Embolism Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Pulmonary Embolism Market

19.1. South East Asia Pulmonary Embolism Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Pulmonary Embolism Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Pulmonary Embolism Market

20.1. Western Europe Pulmonary Embolism Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Pulmonary Embolism Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Pulmonary Embolism Market

21.1. UK Pulmonary Embolism Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Pulmonary Embolism Market

22.1. Germany Pulmonary Embolism Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Pulmonary Embolism Market

23.1. France Pulmonary Embolism Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Pulmonary Embolism Market

24.1. Italy Pulmonary Embolism Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Pulmonary Embolism Market

25.1. Spain Pulmonary Embolism Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Pulmonary Embolism Market

26.1. Eastern Europe Pulmonary Embolism Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Pulmonary Embolism Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Pulmonary Embolism Market

27.1. Russia Pulmonary Embolism Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Pulmonary Embolism Market

28.1. North America Pulmonary Embolism Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Pulmonary Embolism Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Pulmonary Embolism Market

29.1. USA Pulmonary Embolism Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Pulmonary Embolism Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Pulmonary Embolism Market

30.1. Canada Pulmonary Embolism Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Pulmonary Embolism Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Pulmonary Embolism Market

31.1. South America Pulmonary Embolism Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Pulmonary Embolism Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Pulmonary Embolism Market

32.1. Brazil Pulmonary Embolism Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Pulmonary Embolism Market

33.1. Middle East Pulmonary Embolism Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Pulmonary Embolism Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Pulmonary Embolism Market

34.1. Africa Pulmonary Embolism Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Pulmonary Embolism Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Pulmonary Embolism Market Regulatory and Investment Landscape

36. Pulmonary Embolism Market Competitive Landscape And Company Profiles

36.1. Pulmonary Embolism Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Pulmonary Embolism Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Pulmonary Embolism Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Johnson And Johnson Private Limited Overview, Products and Services, Strategy and Financial Analysis

36.3.3. F Hoffmann La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Merck And Co Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

37. Pulmonary Embolism Market Other Major And Innovative Companies

Bayer AG, Sanofi S.A., Bristol Myers Squibb Company, GSK plc, Abbott Laboratories, AstraZeneca plc, Medtronic plc, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Daiichi Sankyo Co. Ltd., Boehringer Ingelheim International GmbH, Mitsubishi Tanabe Pharma Corporation, Genentech Inc., Hikma Pharmaceuticals plc

38. Global Pulmonary Embolism Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Pulmonary Embolism Market

40. Pulmonary Embolism Market High Potential Countries, Segments and Strategies

40.1 Pulmonary Embolism Market In 2030 - Countries Offering Most New Opportunities

40.2 Pulmonary Embolism Market In 2030 - Segments Offering Most New Opportunities

40.3 Pulmonary Embolism Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Pulmonary Embolism Market, Overview Of Key Products - Product Examples
  • Table 2: Global Pulmonary Embolism Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Pulmonary Embolism Market, Supply Chain Analysis
  • Table 4: Global Pulmonary Embolism Market, Major Raw Material Providers
  • Table 5: Global Pulmonary Embolism Market, Major Resource Providers
  • Table 6: Global Pulmonary Embolism Market, Major Manufacturers (Suppliers)
  • Table 7: Global Pulmonary Embolism Market, Major Distributors And Channel Partners
  • Table 8: Global Pulmonary Embolism Market, Key Technologies & Future Trends
  • Table 9: Global Pulmonary Embolism Market, Major Trends
  • Table 10: Global Pulmonary Embolism Market, Major End Users
  • Table 11: Global Pulmonary Embolism Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Pulmonary Embolism Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Pulmonary Embolism Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Pulmonary Embolism Market - TAM, US$ Billion, 2025
  • Table 15: Global Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Pulmonary Embolism Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Pulmonary Embolism Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Pulmonary Embolism Market, Sub-Segmentation Of Medications, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Pulmonary Embolism Market, Sub-Segmentation Of Mechanical Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Pulmonary Embolism Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Pulmonary Embolism Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Pulmonary Embolism Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Global Pulmonary Embolism Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 98: Global Pulmonary Embolism Market - Company Scoring Matrix
  • Table 99: Pfizer Inc. Financial Performance
  • Table 100: Johnson And Johnson Private Limited Financial Performance
  • Table 101: F Hoffmann La Roche Ltd. Financial Performance
  • Table 102: Merck And Co Inc. Financial Performance
  • Table 103: Novartis AG Financial Performance
  • Table 104: Global Pulmonary Embolism Market, Competitive Benchmarking (In USD Billions)
  • Table 105: Global Pulmonary Embolism Market, Competitive Dashboard
  • Table 106: Global Pulmonary Embolism Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 107: Global, Pulmonary Embolism Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030
  • Table 108: Global, Pulmonary Embolism Market Size Gain ($ Billion), Segmentation By Diagnosis, 2025 – 2030
  • Table 109: Global, Pulmonary Embolism Market Size Gain ($ Billion), Segmentation By Symptoms, 2025 – 2030

List Of Figures

    Figure 1: Global Pulmonary Embolism Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Pulmonary Embolism Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Pulmonary Embolism Market, Supply Chain Analysis
  • Figure 4: Global Pulmonary Embolism Market, Major Raw Material Providers
  • Figure 5: Global Pulmonary Embolism Market, Major Resource Providers
  • Figure 6: Global Pulmonary Embolism Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Pulmonary Embolism Market, Major Distributors And Channel Partners
  • Figure 8: Global Pulmonary Embolism Market, Key Technologies & Future Trends
  • Figure 9: Global Pulmonary Embolism Market, Major Trends
  • Figure 10: Global Pulmonary Embolism Market, Major End Users
  • Figure 11: Global Pulmonary Embolism Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Pulmonary Embolism Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Pulmonary Embolism Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Pulmonary Embolism Market - TAM, US$ Billion, 2025
  • Figure 15: Global Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Pulmonary Embolism Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Pulmonary Embolism Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Pulmonary Embolism Market, Sub-Segmentation Of Medications, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Pulmonary Embolism Market, Sub-Segmentation Of Mechanical Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Pulmonary Embolism Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Pulmonary Embolism Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Pulmonary Embolism Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Pulmonary Embolism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Pulmonary Embolism Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Pulmonary Embolism Market, Segmentation By Symptoms, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Global Pulmonary Embolism Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 98: Global Pulmonary Embolism Market - Company Scoring Matrix
  • Figure 99: Pfizer Inc. Financial Performance
  • Figure 100: Johnson And Johnson Private Limited Financial Performance
  • Figure 101: F Hoffmann La Roche Ltd. Financial Performance
  • Figure 102: Merck And Co Inc. Financial Performance
  • Figure 103: Novartis AG Financial Performance
  • Figure 104: Global Pulmonary Embolism Market, Competitive Benchmarking (In USD Billions)
  • Figure 105: Global Pulmonary Embolism Market, Competitive Dashboard
  • Figure 106: Global Pulmonary Embolism Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 107: Global, Pulmonary Embolism Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030
  • Figure 108: Global, Pulmonary Embolism Market Size Gain ($ Billion), Segmentation By Diagnosis, 2025 – 2030
  • Figure 109: Global, Pulmonary Embolism Market Size Gain ($ Billion), Segmentation By Symptoms, 2025 – 2030

Next-Gen Primary Health Care Service : Market Forecast, Transformation, and Long-Term Trajectories

Read More About Next-Gen Primary Health Care Service : Market Forecast, Transformation, and Long-Term Trajectories

Progressive Ataxia And Weakness Disorders Growth Trajectory: Key Forecasts and Strategic Insights

Read More About Progressive Ataxia And Weakness Disorders Growth Trajectory: Key Forecasts and Strategic Insights

Prostate Cancer Nuclear Medicine Diagnostics Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Read More About Prostate Cancer Nuclear Medicine Diagnostics Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Emerging Trends Redefining the Prostate Cancer Nuclear Medicine Diagnostics Market Landscape: Automated Parallel Capillary Electrophoresis Systems Transforming Protein Analysis In The Protein Chip Market

Read More About Emerging Trends Redefining the Prostate Cancer Nuclear Medicine Diagnostics Market Landscape: Automated Parallel Capillary Electrophoresis Systems Transforming Protein Analysis In The Protein Chip Market

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Read More About A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Pulmonary Embolism Market Report 2026 - Global Outlook – By Treatment (Medications, Mechanical Devices, Other Treatments), By Diagnosis (Chest X-Ray, Electrocardiogram (ECG), Magnetic Resonance Imaging (MRI), Computed To...

Vascular Embolization Market Report 2026 - Global Outlook – By Product (Embolic Agents, Embolization Devices), By Embolization Technique (Coiling Devices, Non-Coiling Devices), By Application (Peripheral Vascular Disease...

Venous Thromboembolism Market Report 2026 - Global Outlook – By Type (Deep Vein Thrombosis, Pulmonary Embolism, Other Types), By Treatment (Anti-Clotting Medications,  Mechanical Devices, Thrombolytic Therapy, Other Trea...

Embolization Coils Market Report 2026 - Global Outlook – By Type (Detachable Coil, Pushable Coil), By Material (Platinum, Platinum And Hydrogel, Platinum Tungsten Alloy), By Application (Neurology, Urology, Peripheral Va...

Transcatheter Embolization And Occlusion Devices Market Report 2026 - Global Outlook – By Type (Coil, Non-Coil), By Application (Peripheral Vascular Disease, Oncology, Neurology, Urology, Other Applications), By End User...

Neurovascular Embolization Devices Market Report 2026 - Global Outlook – By Product (Embolization Coils, Liquid Embolic Systems, Flow Diversion Stents, Aneurysm Clips, Other Products), By Treatment (Neurovascular Hemorrh...

Tumor Embolization Devices Market Report 2026 - Global Outlook – By Type (Radioembolic Agents, Non-radioactive Embolic Agents), By Application (Cancer Tumors, Noncancerous Tumors), By End User (Hospitals, Cancer Treatmen...

Pulmonary Arterial Hypertension Market Report 2026 - Global Outlook – By Drug Class (Endothelin Receptor Antagonists (ERAs), PDE-5 Inhibitors, Prostacyclin and Prostacyclin Analogs, SGC Stimulators ), By Route Of Adminis...

Frequently Asked Questions

The Pulmonary Embolism Market Report 2026 market was valued at $2.26 billion in 2025, increased to $2.53 billion in 2026, and is projected to reach $4.14 billion by 2030. request a sample here

The expected CAGR for the Pulmonary Embolism Market Report 2026 market during the forecast period 2025–2030 is 13.1%. request a sample here

Major growth driver of the market includes: Increasing Prevalence Of Cancer To Drive The Growth Of Pulmonary Embolism Market in the Pulmonary Embolism Market Report 2026 market. For further insights on this market, request a sample here

The pulmonary embolism market covered in this report is segmented –
1) By Treatment: Medications, Mechanical Devices, Other Treatments
2) By Diagnosis: Chest X-Ray, Electrocardiogram (ECG), Magnetic Resonance Imaging (MRI), Computed Tomography Scan, Pulmonary Angiography, Venography, Venous Ultrasound, D-Dimer Test, Other Diagnosis
3) By Symptoms: Shortness Of Breath, Chest Pain, Cough, Irregular Heartbeat, Dizziness, Fever, Cyanosis, Other Symptoms
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
5) By End-User: Hospitals, Specialty Clinics, Homecare, Other End-Users Subsegments:
1) By Medications: Anticoagulants, Thrombolytics
2) By Mechanical Devices: Inferior Vena Cava (IVC) Filters, Catheter-Assisted Thrombectomy
3) By Other Treatments: Surgical Embolectomy, Supportive Care request a sample here

Major trend in this market includes: Leading Companies In The Pulmonary Embolism Market Innovate With Advanced Catheter Solutions For further insights on this market, request a sample here.

Major companies operating in the Pulmonary Embolism Market Report 2026 market are Major companies operating in the pulmonary embolism market are Pfizer Inc., Johnson And Johnson Private Limited, F Hoffmann La Roche Ltd., Merck And Co Inc., Novartis AG, Bayer AG, Sanofi S.A., Bristol Myers Squibb Company, GSK plc, Abbott Laboratories, AstraZeneca plc, Medtronic plc, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Daiichi Sankyo Co. Ltd., Boehringer Ingelheim International GmbH, Mitsubishi Tanabe Pharma Corporation, Genentech Inc., Hikma Pharmaceuticals plc, Aspen Pharmacare Holdings Limited, Nippon Shinyaku Co. Ltd., Fresenius Kabi AG, Inari Medical Inc., AngioDynamics Inc., Otsuka Pharmaceutical Co. Ltd., CSL Behring GmbH, Grifols S.A., Octapharma AG, Kedrion S.p.A request a sample here.

North America was the largest region in the pulmonary embolism market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pulmonary embolism market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us